You just read:

Shionogi Presents New Clinical and Non-clinical Data on S-033188, an Investigational Cap-Dependent Endonuclease Inhibitor for Treatment of Influenza, at the 27th European Congress of Clinical Microbiology and Infectious Diseases

News provided by

Shionogi & Co., Ltd.

Apr 24, 2017, 08:00 ET